PMC:7029449 / 8066-8651
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 134 | 250-259 | Species | denotes | 2019-nCoV | Tax:2697049 |
| 135 | 284-292 | Species | denotes | MERS-CoV | Tax:1335626 |
| 136 | 56-75 | Disease | denotes | 2019-nCoV infection | MESH:C000657245 |
| 137 | 460-469 | Disease | denotes | infection | MESH:D007239 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T57 | 56-65 | SP_7 | denotes | 2019-nCoV |
| T56 | 173-183 | GO:0042571 | denotes | antibodies |
| T55 | 250-259 | SP_7 | denotes | 2019-nCoV |
| T54 | 284-292 | SP_9 | denotes | MERS-CoV |
| T53 | 358-368 | GO:0042571 | denotes | antibodies |
| T52 | 426-434 | GO:0042571 | denotes | antibody |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T4 | 426-434 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T39 | 56-75 | Disease | denotes | 2019-nCoV infection | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T40 | 66-75 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T41 | 460-469 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T40 | 375-376 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T45 | 0-205 | Sentence | denotes | Another question on susceptibility is regarding whether 2019-nCoV infection confers neutralising immunity, usually but not always, indicated by the presence of neutralising antibodies in convalescent sera. |
| T46 | 206-374 | Sentence | denotes | Some experts already questioned whether the 2019-nCoV may behave similarly to MERS-CoV in cases exhibiting mild symptoms without eliciting neutralising antibodies [17]. |
| T47 | 375-492 | Sentence | denotes | A separate question pertains to the possibility of antibody-dependent enhancement of infection or of disease [18,19]. |
| T48 | 493-585 | Sentence | denotes | If either of these were to be relevant, the transmission dynamics could become more complex. |